Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Collapse of the Plasmacytoid Dendritic Cells compartment in advanced cutaneous melanomas by components of the tumor cell secretome.

Vescovi R, Monti M, Moratto D, Paolini L, Consoli F, Benerini Gatta L, Melocchi L, Calza S, Chiudinelli M, Rossi G, Bugatti M, Maio M, Fonsatti E, Farisoglio C, Simbolo M, Almici C, Verardi R, Scarpa A, Bergese P, Manganoni A, Facchetti F, Vermi W.

Cancer Immunol Res. 2018 Nov 6. pii: canimm.0141.2018. doi: 10.1158/2326-6066.CIR-18-0141. [Epub ahead of print]

PMID:
30401679
2.

Pityriasis Lichenoides, Atypical Pityriasis Lichenoides, and Related Conditions: A Study of 66 Cases.

Borra T, Custrin A, Saggini A, Fink-Puches R, Cota C, Vermi W, Facchetti F, Cerroni L.

Am J Surg Pathol. 2018 Aug;42(8):1101-1112. doi: 10.1097/PAS.0000000000001093.

PMID:
29851705
3.

NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines.

Huergo-Zapico L, Parodi M, Cantoni C, Lavarello C, Fernández-Martínez JL, Petretto A, DeAndrés-Galiana EJ, Balsamo M, López-Soto A, Pietra G, Bugatti M, Munari E, Marconi M, Mingari MC, Vermi W, Moretta L, González S, Vitale M.

Cancer Res. 2018 Jul 15;78(14):3913-3925. doi: 10.1158/0008-5472.CAN-17-1891. Epub 2018 May 11.

PMID:
29752261
4.

slan+ Monocytes and Macrophages Mediate CD20-Dependent B-cell Lymphoma Elimination via ADCC and ADCP.

Vermi W, Micheletti A, Finotti G, Tecchio C, Calzetti F, Costa S, Bugatti M, Calza S, Agostinelli C, Pileri S, Balzarini P, Tucci A, Rossi G, Furlani L, Todeschini G, Zamò A, Facchetti F, Lorenzi L, Lonardi S, Cassatella MA.

Cancer Res. 2018 Jul 1;78(13):3544-3559. doi: 10.1158/0008-5472.CAN-17-2344. Epub 2018 May 10.

PMID:
29748373
5.

A Reappraisal on the Potential Ability of Human Neutrophils to Express and Produce IL-17 Family Members In Vitro: Failure to Reproducibly Detect It.

Tamassia N, Arruda-Silva F, Calzetti F, Lonardi S, Gasperini S, Gardiman E, Bianchetto-Aguilera F, Gatta LB, Girolomoni G, Mantovani A, Vermi W, Cassatella MA.

Front Immunol. 2018 Apr 17;9:795. doi: 10.3389/fimmu.2018.00795. eCollection 2018.

6.

Myeloid ERK5 deficiency suppresses tumor growth by blocking protumor macrophage polarization via STAT3 inhibition.

Giurisato E, Xu Q, Lonardi S, Telfer B, Russo I, Pearson A, Finegan KG, Wang W, Wang J, Gray NS, Vermi W, Xia Z, Tournier C.

Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):E2801-E2810. doi: 10.1073/pnas.1707929115. Epub 2018 Mar 5.

7.

Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor.

Barrow AD, Edeling MA, Trifonov V, Luo J, Goyal P, Bohl B, Bando JK, Kim AH, Walker J, Andahazy M, Bugatti M, Melocchi L, Vermi W, Fremont DH, Cox S, Cella M, Schmedt C, Colonna M.

Cell. 2018 Jan 25;172(3):534-548.e19. doi: 10.1016/j.cell.2017.11.037. Epub 2017 Dec 21.

PMID:
29275861
8.

Two Distinct Myeloid Subsets at the Term Human Fetal-Maternal Interface.

Costa ML, Robinette ML, Bugatti M, Longtine MS, Colvin BN, Lantelme E, Vermi W, Colonna M, Nelson DM, Cella M.

Front Immunol. 2017 Oct 25;8:1357. doi: 10.3389/fimmu.2017.01357. eCollection 2017.

9.

Helicobacter pylori Affects the Antigen Presentation Activity of Macrophages Modulating the Expression of the Immune Receptor CD300E through miR-4270.

Pagliari M, Munari F, Toffoletto M, Lonardi S, Chemello F, Codolo G, Millino C, Della Bella C, Pacchioni B, Vermi W, Fassan M, de Bernard M, Cagnin S.

Front Immunol. 2017 Oct 12;8:1288. doi: 10.3389/fimmu.2017.01288. eCollection 2017.

10.

Potential contribution of tumor-associated slan+ cells as anti-CSF-1R targets in human carcinoma.

Lonardi S, Licini S, Micheletti A, Finotti G, Vermi W, Cassatella MA.

J Leukoc Biol. 2018 Mar;103(3):559-564. doi: 10.1189/jlb.1MA0717-300R. Epub 2017 Dec 28.

PMID:
28951423
11.

Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis.

Roca E, Gurizzan C, Amoroso V, Vermi W, Ferrari V, Berruti A.

Cancer Treat Rev. 2017 Sep;59:117-122. doi: 10.1016/j.ctrv.2017.07.007. Epub 2017 Jul 31. Review.

PMID:
28806542
12.

Role of MyD88 signaling in the imiquimod-induced mouse model of psoriasis: focus on innate myeloid cells.

Costa S, Marini O, Bevilacqua D, DeFranco AL, Hou B, Lonardi S, Vermi W, Rodegher P, Panato A, Tagliaro F, Lowell CA, Cassatella MA, Girolomoni G, Scapini P.

J Leukoc Biol. 2017 Sep;102(3):791-803. doi: 10.1189/jlb.3MA0217-054RR. Epub 2017 Jun 22.

PMID:
28642279
13.

An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition.

Young HL, Rowling EJ, Bugatti M, Giurisato E, Luheshi N, Arozarena I, Acosta JC, Kamarashev J, Frederick DT, Cooper ZA, Reuben A, Gil J, Flaherty KT, Wargo JA, Vermi W, Smith MP, Wellbrock C, Hurlstone A.

J Exp Med. 2017 Jun 5;214(6):1691-1710. doi: 10.1084/jem.20160855. Epub 2017 Apr 27.

14.

IL-21 May Promote Granzyme B-Dependent NK/Plasmacytoid Dendritic Cell Functional Interaction in Cutaneous Lupus Erythematosus.

Salvi V, Vermi W, Cavani A, Lonardi S, Carbone T, Facchetti F, Bosisio D, Sozzani S.

J Invest Dermatol. 2017 Jul;137(7):1493-1500. doi: 10.1016/j.jid.2017.03.016. Epub 2017 Mar 23.

15.

Mature CD10+ and immature CD10- neutrophils present in G-CSF-treated donors display opposite effects on T cells.

Marini O, Costa S, Bevilacqua D, Calzetti F, Tamassia N, Spina C, De Sabata D, Tinazzi E, Lunardi C, Scupoli MT, Cavallini C, Zoratti E, Tinazzi I, Marchetta A, Vassanelli A, Cantini M, Gandini G, Ruzzenente A, Guglielmi A, Missale F, Vermi W, Tecchio C, Cassatella MA, Scapini P.

Blood. 2017 Mar 9;129(10):1343-1356. doi: 10.1182/blood-2016-04-713206. Epub 2017 Jan 4. Erratum in: Blood. 2017 Jun 15;129(24):3271.

16.

Correction: slanDCs/M-DC8+ cells constitute a distinct subset of dendritic cells in human tonsils.

Micheletti A, Finotti G, Calzetti F, Lonardi S, Zoratti E, Bugatti M, Stefini S, Vermi W, Cassatella MA.

Oncotarget. 2016 Oct 4;7(40):66323. doi: 10.18632/oncotarget.12418. No abstract available.

17.

Dendritic cell-derived VEGF-A plays a role in inflammatory angiogenesis of human secondary lymphoid organs and is driven by the coordinated activation of multiple transcription factors.

Salvi V, Vermi W, Gianello V, Lonardi S, Gagliostro V, Naldini A, Sozzani S, Bosisio D.

Oncotarget. 2016 Jun 28;7(26):39256-39269. doi: 10.18632/oncotarget.9684.

18.

Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary Carcinomas.

Griffith OL, Chan SR, Griffith M, Krysiak K, Skidmore ZL, Hundal J, Allen JA, Arthur CD, Runci D, Bugatti M, Miceli AP, Schmidt H, Trani L, Kanchi KL, Miller CA, Larson DE, Fulton RS, Vermi W, Wilson RK, Schreiber RD, Mardis ER.

Cell Rep. 2016 Sep 27;17(1):249-260. doi: 10.1016/j.celrep.2016.08.076.

19.

TLR Signalling Pathways Diverge in Their Ability to Induce PGE2.

Salvi V, Vaira X, Gianello V, Vermi W, Bugatti M, Sozzani S, Bosisio D.

Mediators Inflamm. 2016;2016:5678046. doi: 10.1155/2016/5678046. Epub 2016 Aug 18.

20.

p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity.

Adriaens C, Standaert L, Barra J, Latil M, Verfaillie A, Kalev P, Boeckx B, Wijnhoven PW, Radaelli E, Vermi W, Leucci E, Lapouge G, Beck B, van den Oord J, Nakagawa S, Hirose T, Sablina AA, Lambrechts D, Aerts S, Blanpain C, Marine JC.

Nat Med. 2016 Aug;22(8):861-8. doi: 10.1038/nm.4135. Epub 2016 Jul 4.

PMID:
27376578
21.

Impairment of dendritic cell functions in patients with adaptor protein-3 complex deficiency.

Prandini A, Salvi V, Colombo F, Moratto D, Lorenzi L, Vermi W, De Francesco MA, Notarangelo LD, Porta F, Plebani A, Facchetti F, Sozzani S, Badolato R.

Blood. 2016 Jun 30;127(26):3382-6. doi: 10.1182/blood-2015-06-650689. Epub 2016 May 13.

22.

Intrafollicular Epstein-Barr virus-positive large B cell lymphoma. A variant of "germinotropic" lymphoproliferative disorder.

Lorenzi L, Lonardi S, Essatari MH, Pellegrini V, Fisogni S, Gazzola A, Agostinelli C, Vermi W, Rossi G, Massarelli G, Pileri SA, Facchetti F.

Virchows Arch. 2016 Apr;468(4):441-50. doi: 10.1007/s00428-015-1902-9. Epub 2016 Jan 13.

PMID:
26762526
23.

Neoplasms derived from plasmacytoid dendritic cells.

Facchetti F, Cigognetti M, Fisogni S, Rossi G, Lonardi S, Vermi W.

Mod Pathol. 2016 Feb;29(2):98-111. doi: 10.1038/modpathol.2015.145. Epub 2016 Jan 8. Review.

24.

slanDCs/M-DC8+ cells constitute a distinct subset of dendritic cells in human tonsils [corrected].

Micheletti A, Finotti G, Calzetti F, Lonardi S, Zoratti E, Bugatti M, Stefini S, Vermi W, Cassatella MA.

Oncotarget. 2016 Jan 5;7(1):161-75. doi: 10.18632/oncotarget.6660. Erratum in: Oncotarget. 2016 Oct 4;7(40):66323.

25.

Sinonasal mucosal melanoma: A 12-year experience of 58 cases.

Lombardi D, Bottazzoli M, Turri-Zanoni M, Raffetti E, Villaret AB, Morassi ML, Ungari M, Vermi W, Battaglia P, Castelnuovo P, Facco C, Sessa F, Donato F, Nicolai P.

Head Neck. 2016 Apr;38 Suppl 1:E1737-45. doi: 10.1002/hed.24309. Epub 2015 Dec 17.

PMID:
26676523
26.

Nonredundant roles of keratinocyte-derived IL-34 and neutrophil-derived CSF1 in Langerhans cell renewal in the steady state and during inflammation.

Wang Y, Bugatti M, Ulland TK, Vermi W, Gilfillan S, Colonna M.

Eur J Immunol. 2016 Mar;46(3):552-9. doi: 10.1002/eji.201545917. Epub 2015 Dec 28.

27.

BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations.

Cigognetti M, Lonardi S, Fisogni S, Balzarini P, Pellegrini V, Tironi A, Bercich L, Bugatti M, Rossi G, Murer B, Barbareschi M, Giuliani S, Cavazza A, Marchetti G, Vermi W, Facchetti F.

Mod Pathol. 2015 Aug;28(8):1043-57. doi: 10.1038/modpathol.2015.65. Epub 2015 May 29.

28.

OSCAR is a receptor for surfactant protein D that activates TNF-α release from human CCR2+ inflammatory monocytes.

Barrow AD, Palarasah Y, Bugatti M, Holehouse AS, Byers DE, Holtzman MJ, Vermi W, Skjødt K, Crouch E, Colonna M.

J Immunol. 2015 Apr 1;194(7):3317-26. doi: 10.4049/jimmunol.1402289. Epub 2015 Feb 25.

29.

Correction: Dual Function of CD70 in Viral Infection: Modulator of Early Cytokine Responses and Activator of Adaptive Responses.

Allam A, Swiecki M, Vermi W, Ashwell JD, Colonna M.

J Immunol. 2015 Feb 15;194(4):2033. doi: 10.4049/jimmunol.1490050. No abstract available.

30.

ALK testing in lung adenocarcinoma: technical aspects to improve FISH evaluation in daily practice.

Martin V, Bernasconi B, Merlo E, Balzarini P, Vermi W, Riva A, Chiaravalli AM, Frattini M, Sahnane N, Facchetti F, Mazzucchelli L, Sessa F, Tibiletti MG.

J Thorac Oncol. 2015 Apr;10(4):595-602. doi: 10.1097/JTO.0000000000000444.

31.

Characterization of the immune cell repertoire in the normal fallopian tube.

Ardighieri L, Lonardi S, Moratto D, Facchetti F, Shih IeM, Vermi W, Kurman RJ.

Int J Gynecol Pathol. 2014 Nov;33(6):581-91. doi: 10.1097/PGP.0000000000000095.

32.

The Muir-Torre syndrome: a typical case of misdiagnosis and consequent worsened prognosis.

Baiocchi GL, Chiocchi E, Vermi W, Molfino S, Gheza F, Biasca F, Portolani N, Giulini SM.

Int J Colorectal Dis. 2015 Mar;30(3):431-2. doi: 10.1007/s00384-014-2010-z. Epub 2014 Sep 13. No abstract available.

PMID:
25213586
33.

Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model.

Rowland SL, Riggs JM, Gilfillan S, Bugatti M, Vermi W, Kolbeck R, Unanue ER, Sanjuan MA, Colonna M.

J Exp Med. 2014 Sep 22;211(10):1977-91. doi: 10.1084/jem.20132620. Epub 2014 Sep 1.

34.

Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity.

Spoto B, Di Betta E, Mattace-Raso F, Sijbrands E, Vilardi A, Parlongo RM, Pizzini P, Pisano A, Vermi W, Testa A, Cutrupi S, D'Arrigo G, Lonardi S, Tripepi G, Cancarini G, Zoccali C.

Nutr Metab Cardiovasc Dis. 2014 Oct;24(10):1137-43. doi: 10.1016/j.numecd.2014.04.017. Epub 2014 May 27.

PMID:
24984824
35.

Dual function of CD70 in viral infection: modulator of early cytokine responses and activator of adaptive responses.

Allam A, Swiecki M, Vermi W, Ashwell JD, Colonna M.

J Immunol. 2014 Jul 15;193(2):871-8. doi: 10.4049/jimmunol.1302429. Epub 2014 Jun 9. Erratum in: J Immunol. 2015 Feb 15;194(4):2033.

36.

Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant.

Mimiola E, Marini O, Perbellini O, Micheletti A, Vermi W, Lonardi S, Costantini C, Meneghelli E, Andreini A, Bonetto C, Vassanelli A, Cantini M, Zoratti E, Massi D, Zamo' A, Leso A, Quaresmini G, Benedetti F, Pizzolo G, Cassatella MA, Tecchio C.

Clin Exp Immunol. 2014 Oct;178(1):129-41. doi: 10.1111/cei.12387.

37.

slanDCs in carcinoma-draining lymph nodes.

Vermi W, Lonardi S, Bugatti M, Calzetti F, Micheletti A, Cassatella MA.

Oncoimmunology. 2014 Jan 1;3(3):e28246. Epub 2014 Mar 17.

38.

The Emerging Role of NRAS Mutations in Colorectal Cancer Patients Selected for Anti-EGFR Therapies.

Meriggi F, Vermi W, Bertocchi P, Zaniboni A.

Rev Recent Clin Trials. 2014;9(1):8-12. Review.

PMID:
24758538
39.

Cell depletion in mice that express diphtheria toxin receptor under the control of SiglecH encompasses more than plasmacytoid dendritic cells.

Swiecki M, Wang Y, Riboldi E, Kim AH, Dzutsev A, Gilfillan S, Vermi W, Ruedl C, Trinchieri G, Colonna M.

J Immunol. 2014 May 1;192(9):4409-16. doi: 10.4049/jimmunol.1303135. Epub 2014 Mar 28.

40.

Lynch syndrome from a surgeon perspective: retrospective study of clinical impact of mismatch repair protein expression analysis in colorectal cancer patients less than 50 years old.

Baiocchi GL, Portolani N, Vermi W, Baronchelli C, Gheza F, Zogno C, Scaglia A, Marchina E, Tiberio GA, Giulini SM.

BMC Surg. 2014 Feb 17;14:9. doi: 10.1186/1471-2482-14-9.

41.

slanDCs selectively accumulate in carcinoma-draining lymph nodes and marginate metastatic cells.

Vermi W, Micheletti A, Lonardi S, Costantini C, Calzetti F, Nascimbeni R, Bugatti M, Codazzi M, Pinter PC, Schäkel K, Tamassia N, Cassatella MA.

Nat Commun. 2014;5:3029. doi: 10.1038/ncomms4029.

PMID:
24398631
42.

Occurrence of nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome is associated to natural killer and natural killer T cell defects.

Lorenzi L, Tabellini G, Vermi W, Moratto D, Porta F, Notarangelo LD, Patrizi O, Sozzani S, de Saint Basile G, Latour S, Pace D, Lonardi S, Facchetti F, Badolato R, Parolini S.

PLoS One. 2013 Nov 26;8(11):e80131. doi: 10.1371/journal.pone.0080131. eCollection 2013.

43.

Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells.

Ronca R, Di Salle E, Giacomini A, Leali D, Alessi P, Coltrini D, Ravelli C, Matarazzo S, Ribatti D, Vermi W, Presta M.

Mol Cancer Ther. 2013 Dec;12(12):2760-71. doi: 10.1158/1535-7163.MCT-13-0487. Epub 2013 Oct 15.

44.

Dysregulated STAT1-SOCS1 control of JAK2 promotes mammary luminal progenitor cell survival and drives ERα(+) tumorigenesis.

Chan SR, Rickert CG, Vermi W, Sheehan KC, Arthur C, Allen JA, White JM, Archambault J, Lonardi S, McDevitt TM, Bhattacharya D, Lorenzi MV, Allred DC, Schreiber RD.

Cell Death Differ. 2014 Feb;21(2):234-46. doi: 10.1038/cdd.2013.116. Epub 2013 Sep 13.

45.

Ligand-dependent activation of EGFR in follicular dendritic cells sarcoma is sustained by local production of cognate ligands.

Vermi W, Giurisato E, Lonardi S, Balzarini P, Rossi E, Medicina D, Bosisio D, Sozzani S, Pellegrini W, Doglioni C, Marchetti A, Rossi G, Pileri S, Facchetti F.

Clin Cancer Res. 2013 Sep 15;19(18):5027-38. doi: 10.1158/1078-0432.CCR-13-1275. Epub 2013 Jul 25.

46.

BDCA-2 (CD303): a highly specific marker for normal and neoplastic plasmacytoid dendritic cells.

Boiocchi L, Lonardi S, Vermi W, Fisogni S, Facchetti F.

Blood. 2013 Jul 11;122(2):296-7. doi: 10.1182/blood-2013-05-500413. No abstract available.

47.

Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells.

Fuchs A, Vermi W, Lee JS, Lonardi S, Gilfillan S, Newberry RD, Cella M, Colonna M.

Immunity. 2013 Apr 18;38(4):769-81. doi: 10.1016/j.immuni.2013.02.010. Epub 2013 Feb 28.

48.

Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer.

Ronca R, Alessi P, Coltrini D, Di Salle E, Giacomini A, Leali D, Corsini M, Belleri M, Tobia C, Garlanda C, Bonomi E, Tardanico R, Vermi W, Presta M.

J Pathol. 2013 Jun;230(2):228-38. doi: 10.1002/path.4181.

PMID:
23424081
49.

Wiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells.

Prete F, Catucci M, Labrada M, Gobessi S, Castiello MC, Bonomi E, Aiuti A, Vermi W, Cancrini C, Metin A, Hambleton S, Bredius R, Notarangelo LD, van der Burg M, Kalinke U, Villa A, Benvenuti F.

J Exp Med. 2013 Feb 11;210(2):355-74. doi: 10.1084/jem.20120363. Epub 2013 Jan 21.

50.

Melanoma immunoediting by NK cells.

Balsamo M, Pietra G, Vermi W, Moretta L, Mingari MC, Vitale M.

Oncoimmunology. 2012 Dec 1;1(9):1607-1609.

Supplemental Content

Support Center